Charles River

Charles River

Charles River transforms drug development with 75+ years of expertise across Discovery, Safety Assessment, and Toxicology, from Lead Optimization to GLP/Non-GLP studies (General, Immunology, Genetic, Ocular, Neuro, Developmental, Reproductive, and more). With 150+ sites in 21 countries, we drive innovation through integrated solutions and groundbreaking initiatives like Virtual Control Groups (VCGs), blending science with machine learning to deliver transformative alternatives. Apollo™, our industry-leading platform, provides real-time access to study data, enabling faster decisions, advanced visualization, and self-serve analytics. At Charles River, we deliver precision, efficiency, and confidence to accelerate life-saving therapies—because every moment matters for patients in need.

Acute Toxicology Services/Testing, Bioanalytical Services, Biomarkers, CRO—Contract Research Organization, Cancer Biology/Carcinogenicity, Chronic Toxicology, Developmental Toxicology, GLP—Good Laboratory Practice Services, Genotoxicity Products/Services, Neurobiology/Neurotoxicology, Ophthalmic Research/Testing, Photo-Biology/Toxicology Services/Testing, Reproductive Toxicology, Respiratory Toxicology, Safety Assessment